COUNTY HALL | LONDON | SAVE THE DATE: 18 April, 2024
At the 19th Annual Anglonordic Life Science Conference, over 300 delegates:
MET decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe.
LEARNED from major investment firms about the current status of European investment in life science technologies.
GAINED insights from experienced life science operators within the Anglo-Nordic space.
Anglonordic has a 20-year tradition as an invitation-only gathering of investors and R&D growth companies that consistently offers unique opportunities for funding and collaboration.
Read the latest edition of Nordic Lifescience Magazine free!
73 Investor Firms
275 Partnering Meetings
26 Startup Pitches
Exclusively selected attendees represented the following key drivers of the European life sciences growth sector:
- CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic sphere and Continental Europe
- Decision-makers from Europe's key Investor firms and Pharma companies
- Key Supporters of the Life Science Ecosystem in Europe
The following 73 investment firms signed up for Anglonordic 2023, with interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices:
COUNTY HALL | LONDON | 20 April, 2023
Anglonordic Life Science Conference Partnering is generously sponsored by Scantox